tooluniverse-precision-oncology
Provide actionable treatment recommendations for cancer patients based on molecular profile. Interprets tumor mutations, identifies FDA-approved therapies, finds resistance mechanisms, matches clinical trials. Use when oncologist asks about treatment options for specific mutations (EGFR, KRAS, BRAF, etc.), therapy resistance, or clinical trial eligibility.
55
63%
Does it follow best practices?
Run evals on this skill
Adds up to 20 points to the overall score
View guide
Low
Low-risk findings worth noting
Fix and improve this skill with Tessl
tessl review fix ./skills/med/tooluniverse-precision-oncology/SKILL.mdLow
Low-risk findings.
1 low severity finding. Worth noting, but not necessarily harmful.
W011: Third-party content exposure detected (indirect prompt injection risk).
What this means
The skill exposes the agent to untrusted, user-generated content from public third-party sources, creating a risk of indirect prompt injection. This includes browsing arbitrary URLs, reading social media posts or forum comments, and analyzing content from unknown websites.
Why it was flagged
The workflow reads external first-party biomedical records (e.g., via tool calls like `civic_search_variants`/`civic_get_variant`, `search_clinical_trials`/`get_clinical_trial_eligibility_criteria`, and PubMed/BioRxiv/MedRxiv/OpenAlex searches) rather than any outsider-authored free-text submission path that would let an attacker poison arbitrary text “fed” into the agent without an explicit, trusted search/fetch step.
- Repository
- wu-yc/LabClaw
- Commit
df37802
- Audited
- Security analysis
Is this your skill?
If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.